Registered number
07185445
Lisa Tan Pharma Consulting Limited
Filleted Accounts
31 March 2026

Lisa Tan Pharma Consulting Limited
Registered number: | 07185445
Balance Sheet
as at 31 March 2026
Notes |  |  | 2026 |  |  | 2025
£ | £
Fixed assets
Tangible assets | 4 |  |  | 36,408 |  |  | 48,718
Investments | 5 |  |  | 111,306 |  |  | -
|  |  |  | 147,714 |  |  | 48,718
Current assets
Debtors | 6 |  | 55,199 |  |  | 35,391
Cash at bank and in hand |  |  | 896,950 |  |  | 963,355
|  |  | 952,149 |  |  | 998,746
Creditors: amounts falling due within one year | 7 |  | (50,180) |  |  | (64,098)
Net current assets |  |  |  | 901,969 |  |  | 934,648
Total assets less current liabilities |  |  |  | 1,049,683 |  |  | 983,366
Provisions for liabilities |  |  |  | (9,101) |  |  | (12,178)
Net assets |  |  |  | 1,040,582 |  |  | 971,188
Capital and reserves
Called up share capital |  |  |  | 100 |  |  | 100
Profit and loss account |  |  |  | 1,040,482 |  |  | 971,088
Shareholders' funds |  |  |  | 1,040,582 |  |  | 971,188
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mrs E F Tan
Director
Approved by the board on 7 August 2026

Lisa Tan Pharma Consulting Limited
Notes to the Accounts
for the year ended 31 March 2026
1 | Accounting policies
| Basis of preparation
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
| Going concern
| The financial statements have been prepared on a going concern basis. The directors have made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company’s ability to continue as a going concern for the period of at least 12 months from the date of approval of these financial statements.
| Turnover
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
| Tangible fixed assets
| Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
| Motor Vehicles | 25%
| Fixtures, fittings and equipment | 20% - 33%
| Investments
| Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
| Debtors
| Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
| Creditors
| Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
| Taxation
| A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
| Foreign currency translation
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
| Pensions
| Contributions to defined contribution plans are expensed in the period to which they relate.
2 | Taxation | 2026 |  | 2025
£ | £
| Corporation tax | 34,964 |  | 49,167
| Deferred tax | (3,077) |  | 4,225
|  |  |  |  |  | 31,887 |  | 53,392
3 | Employees | 2026 |  | 2025
Number | Number
| Average number of persons employed by the company | 1 |  | 1
4 | Tangible fixed assets
|  |  |  | Plant and machinery etc |  | Motor vehicles |  | Total
£ | £ | £
| Cost
| At 1 April 2025 | 30,983 |  | 53,791 |  | 84,774
| Disposals | (5,509) |  | - |  | (5,509)
| At 31 March 2026 | 25,474 |  | 53,791 |  | 79,265
| Depreciation
| At 1 April 2025 | 12,523 |  | 23,533 |  | 36,056
| Charge for the year | 4,745 |  | 7,565 |  | 12,310
| On disposals | (5,509) |  | - |  | (5,509)
| At 31 March 2026 | 11,759 |  | 31,098 |  | 42,857
| Net book value
| At 31 March 2026 | 13,715 |  | 22,693 |  | 36,408
| At 31 March 2025 | 18,460 |  | 30,258 |  | 48,718
5 | Investments
Other
investments
£
| Cost
| Additions | 244,522
| Disposals | (138,067)
| Revaluation | 4,851
| At 31 March 2026 | 111,306
6 | Debtors | 2026 |  | 2025
£ | £
| Trade debtors | 15,120 |  | 15,058
| Other debtors | 40,079 |  | 20,333
|  |  |  |  |  | 55,199 |  | 35,391
7 | Creditors: amounts falling due within one year | 2026 |  | 2025
£ | £
| Taxation and social security costs | 49,160 |  | 63,119
| Other creditors | 1,020 |  | 979
|  |  |  |  |  | 50,180 |  | 64,098
8 | Loans to directors
B/fwd | Paid | Repaid | C/fwd
£ | £ | £ | £
| Directors loan account E Tan | 222 |  | 12,442 |  | (2,694) |  | 9,970
| Directors loan account K Tan | - |  | 10,000 |  |  |  | 10,000
|  | 222 |  | 22,442 |  | (2,694) |  | 19,970
| Interest has been charged at a rate of 3.75% on the directors loan. The balance outstanding at the end of the year has been repaid within 9 months after the year end.
9 | Related party transactions
| The company loaned £20,000 to Melanie Verdejo Properties Limited, this loan is interest free and is repayable once the company has sufficient funds. The amount outstanding at the year end is £20,000 (2025:£20,000).
10 | Other information
| Lisa Tan Pharma Consulting Limited is a private company limited by shares and incorporated in England. Its registered office is:
| ntrust Accountancy Ltd, Ground Floor, Suite 6
| LDH House
| Parsons Green
| St Ives
| PE27 4AA

Lisa Tan Pharma Consulting Limited 07185445 false 2025-04-01 2026-03-31 2026-03-31 VT Final Accounts May 2026 Mrs E F Tan No description of principal activity 07185445 2024-04-01 2025-03-31 07185445 core:WithinOneYear 2025-03-31 07185445 core:ShareCapital 2025-03-31 07185445 core:RetainedEarningsAccumulatedLosses 2025-03-31 07185445 2025-04-01 2026-03-31 07185445 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 07185445 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 07185445 bus:Director40 2025-04-01 2026-03-31 07185445 1 2025-04-01 2026-03-31 07185445 2 2025-04-01 2026-03-31 07185445 core:PlantMachinery 2025-04-01 2026-03-31 07185445 core:Vehicles 2025-04-01 2026-03-31 07185445 bus:Director1 1 2025-04-01 2026-03-31 07185445 countries:England 2025-04-01 2026-03-31 07185445 bus:FRS102 2025-04-01 2026-03-31 07185445 bus:FilletedAccounts 2025-04-01 2026-03-31 07185445 2026-03-31 07185445 core:WithinOneYear 2026-03-31 07185445 core:ShareCapital 2026-03-31 07185445 core:RetainedEarningsAccumulatedLosses 2026-03-31 07185445 core:PlantMachinery 2026-03-31 07185445 core:Vehicles 2026-03-31 07185445 core:AdditionsToInvestments 2026-03-31 07185445 core:DisposalsRepaymentsInvestments 2026-03-31 07185445 core:RevaluationsIncreaseDecreaseInInvestments 2026-03-31 07185445 bus:Director1 1 2026-03-31 07185445 2025-03-31 07185445 core:PlantMachinery 2025-03-31 07185445 core:Vehicles 2025-03-31 07185445 bus:Director1 1 2025-03-31 iso4217:GBP xbrli:pure